Markey John 13D and 13G filings for Sonnet BioTherapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-02 4:45 pm Purchase |
2024-01-02 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 24,788 6.500% |
24,788 (New Position) |
Filing |
| 2024-01-02 4:19 pm Sale |
2024-01-02 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 24,788 6.500% |
-4,102 (-14.20%) |
Filing |
| 2023-11-17 11:32 am Purchase |
2023-11-17 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 28,889 7.600% |
4,417 (+18.05%) |
Filing |
| 2023-11-06 11:35 am Purchase |
2023-11-06 | 13G | Sonnet BioTherapeutics Holdings, Inc. SONN |
Markey John | 24,473 6.400% |
24,473 (New Position) |
Filing |